Its the formulation that is key. You can buy these separately but the combination and dose are key. many drugs like this that are formulated just right for their effect. Ask any pharmacist, dose is most important thing along with chemical interactions.
Hmmm. That is true . You are correct, data was complete at December 31. I think there is a better than 500 percent chance of positive trial. Given that it is pancreatic cancer I think at most a 10% chance of blow out results. If so. boom!! They will certainly have the best treatment for the hardest type of cancer to treat and $75 will be the price in 1 week
Seeking alpha gives a 50% chance of success. so does analyst who lowered target. Both say that if it is a failure, buy the heck out of it because the real value and success probability in ADRO is their other trials.
Aduro Biotech is a cancer immunotherapy company with their lead asset, GVAX+CRS-207, in a phase 2b trial for metastatic pancreatic cancer called ECLIPSE with top line data expected 2Q16.
This is smack in the middle of 2Q16. The news timing is a bad sign. If the patients were still alive, then we would have to wait for the data longer than usual. If, of course, this is about top line results which it likely is
CNN and the press and big pharma would be all over ADRO if they have significantly positive pancreatic cancer results. This is the toughest cancer. Would blow away the pharmaceutical industry. 10 billion market cap overnite
They can still work very close to Israeli companies and have a high status headquarters in La Jolla or Durham. Bring the stock to five. This should be the highest priority unless there is enough cash before high revenue generation but this is not likely with costs of 8040.
They must move. They MUST!! There will never be respect for this company and they will be forced to dilute to penny stock status unless they get some respect.
1 New CEO
2 MOVE out of Israel - this is MANDATORY.
They absolutely need to get out of Israel or at the very least make their headquarters in the US. This will attract MUCH more investment interest,
The stock price also needs to be above 5 and a reverse split to get there will work if they do it right. look at ADXS. Just need to be VERY VERY careful of dilution
38 percent complete remission sounds great except:
Compared to WHAT?
What was the remission in control??
How does this compare to other drugs??
How did the other 62% fare? How are they monitored??
NO ^(&#() DATA
Investors dont know if it worked well or not??? If it did, you missed a chance to have your stock at $4 now instead of $1. If it did work, then you are the worst %*^# communicator, WORST *^*&&( CEO TO EVER MANAGE A PUBLIC COMPANY SINCE ENRON